These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

499 related items for PubMed ID: 29696467

  • 1. Ocular sebaceous gland carcinoma: an update of the literature.
    Cicinelli MV, Kaliki S.
    Int Ophthalmol; 2019 May; 39(5):1187-1197. PubMed ID: 29696467
    [Abstract] [Full Text] [Related]

  • 2. Sebaceous gland carcinoma of the ocular adnexa - variability in clinical and histological appearance with analysis of immunohistochemical staining patterns.
    Schmitz EJ, Herwig-Carl MC, Holz FG, Loeffler KU.
    Graefes Arch Clin Exp Ophthalmol; 2017 Nov; 255(11):2277-2285. PubMed ID: 28741159
    [Abstract] [Full Text] [Related]

  • 3. Clinical relevance of cyclooxygenase 2 and peroxisome proliferator-activated receptor γ in eyelid sebaceous gland carcinoma.
    Jayaraj P, Sen S, Bhattacharya T, Arora J, Yadav S, Chhoker V, Kumar A, Dhanaraj PS, Yadavilli KS, Verma M.
    Histopathology; 2016 Aug; 69(2):268-75. PubMed ID: 26791964
    [Abstract] [Full Text] [Related]

  • 4. Ocular Sebaceous Carcinoma In Situ With Biphenotypic Differentiation: A Reappraisal of the Alternative Origin of the Tumor.
    Yim CL, Lam SC, Yuen HKL, Cheuk W.
    Int J Surg Pathol; 2020 Dec; 28(8):888-892. PubMed ID: 32363990
    [Abstract] [Full Text] [Related]

  • 5. Reverse masquerade: primary eyelid amyloidosis mimicking sebaceous gland carcinoma.
    Shahid Alam M.
    Orbit; 2022 Jun; 41(3):392. PubMed ID: 33779482
    [No Abstract] [Full Text] [Related]

  • 6. Clinicopathological features of considerable reduction in androgen receptor expression in sebaceous gland carcinoma of the eyelid.
    Yunoki T, Miyakoshi A, Otsuka M, Hayashi A.
    Int Ophthalmol; 2019 Aug; 39(8):1703-1708. PubMed ID: 30027448
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. CDKN2A, CDK1, and CCNE1 overexpression in sebaceous gland carcinoma of eyelid.
    Yunoki T, Hirano T, Tabuchi Y, Furusawa Y, Torigoe M, Nakajima T, Imura J, Hayashi A.
    Int Ophthalmol; 2020 Feb; 40(2):343-350. PubMed ID: 31571090
    [Abstract] [Full Text] [Related]

  • 9. ZEB2/SIP1 as novel prognostic indicator in eyelid sebaceous gland carcinoma.
    Bhardwaj M, Sen S, Sharma A, Kashyap S, Chosdol K, Pushker N, Bajaj MS, Bakhshi S.
    Hum Pathol; 2015 Oct; 46(10):1437-42. PubMed ID: 26220160
    [Abstract] [Full Text] [Related]

  • 10. Collision tumor of sebaceous carcinoma and squamous cell carcinoma of the eyelid: Case report.
    Wang JJ, Lee KF, Chen CY.
    Eur J Ophthalmol; 2022 Sep; 32(5):NP55-NP59. PubMed ID: 34011202
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Prognosis of eyelid sebaceous gland carcinoma based on the tumor (T) category of the American Joint Committee on Cancer (AJCC) classification.
    Kaliki S, Gupta A, Ali MH, Ayyar A, Naik MN.
    Int Ophthalmol; 2016 Oct; 36(5):681-90. PubMed ID: 26830096
    [Abstract] [Full Text] [Related]

  • 16. Sebaceous carcinoma presenting as a unilateral papillary conjunctivitis.
    Gloor P, Ansari I, Sinard J.
    Am J Ophthalmol; 1999 Apr; 127(4):458-9. PubMed ID: 10218701
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Molecular landscape of eyelid sebaceous gland carcinoma: A comprehensive review.
    Jayaraj P, Ray D, Goel K, Singh A, Kant N, Sen S.
    Indian J Ophthalmol; 2024 Oct 01; 72(10):1393-1403. PubMed ID: 39331429
    [Abstract] [Full Text] [Related]

  • 20. Sebaceous carcinoma of the eyelids: personal experience with 60 cases.
    Shields JA, Demirci H, Marr BP, Eagle RC, Shields CL.
    Ophthalmology; 2004 Dec 01; 111(12):2151-7. PubMed ID: 15582067
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.